1. A potential solution to immunosuppression of the tumour microenvironment: results of a phase 1 clinical trial of anti-OX-40 in head and neck squamous cell carcinoma. (March 2017) Authors: Leidner, R.; Crittenden, M.; Gough, M.; Fox, B.A.; Weinberg, A.D.; Dierks, E.J.; Bell, R.B. Journal: International journal of oral & maxillofacial surgery Issue: Volume 46(2017)Supplement 1 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗